2nd Integrin-Targeted Drug Development Summit
Evvnt Promotion / evvnt
Archivio
31.08.2022 - 01.09.2022 Hilton Boston Logan Airport, One Hotel Drive, 02128 Boston, Massachusetts, USA
Time: 08:30 - 16:00
Temi della conferenza
Over the last 12 months, the industry has witnessed promising data and candidates entering the clinic. 7 Hills Pharma, Corbus Pharmaceuticals, Vincerx, and Morphic are paving the way to develop a safe, efficacious integrins-targeted drug to modify disease biology, which will be a game-changer for diseases such as oncology, autoimmune, and ophthalmology, with unmet medical needs.
Over the last 12 months, the industry has witnessed promising data and candidates entering the clinic. 7 Hills Pharma, Corbus Pharmaceuticals, Vincerx, and Morphic are paving the way to develop a safe, efficacious integrins-targeted drug to modify disease biology, which will be a game-changer for diseases such as oncology, autoimmune, and ophthalmology, with unmet medical needs.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/1173725-3?pid=4832
Speakers: Bernhard Wehrle-Haller, Professor, Geneva University, Bruce Rogers, President, Morphic Therapeutics, Darren G. Woodside, Vice President of Research, Texas Heart Institute, and more.
Brochure: https://go.evvnt.com/1173725-3?pid=4832
Speakers: Bernhard Wehrle-Haller, Professor, Geneva University, Bruce Rogers, President, Morphic Therapeutics, Darren G. Woodside, Vice President of Research, Texas Heart Institute, and more.
Informazioni ed Iscrizioni:
https://go.evvnt.com/1173725-2?pid=4832
Ms. Erin Thomas
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
